Form D · Other Health Care

PROFUSA, Inc.

South San Francisco, CA · CIK 0001479362

Offering snapshot reported Sep 4, 2018 · SEC filing

Reported sold
$45.1M
Offering amount: $50M
Investors reported
46
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 15, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 4, 2018Initial$45,061,613No comparison46SEC filing
Jul 2, 2015Initial$11,259,301No comparison32SEC filing
Sep 6, 2013Initial$2,759,821No comparison29SEC filing
Aug 30, 2012Amendment$1,200,000No comparison17SEC filing
Oct 20, 2011InitialYet to sellNo comparison0SEC filing
Dec 30, 2009InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-320601
Includes the dollar amount for the conversion of the principal and interest of convertible promissory notes.

Source: Form D, filed Sep 4, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joan Braddi Director
William Frist Director
Thomas Gutshall Director
Robert Hawn Executive
Kristen Helton Director, Executive
Ben Hwang Director, Executive
Qianye Karen Liu Director
Bill Mc Millan Executive
William Mc Millan Director, Executive
Ng Siu Wai Director
Natalie Wisniewski Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
345 Allerton Ave.
South San Francisco, CA, 94080